Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 5/20 | 0.71 |
| ▸ | EPHA2 | P29317 | 3/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.71 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.71 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.71 |
| ▸ | LMNA | P02545 | 2/20 | 0.71 |
| ▸ | EFNA1 | P20827 | 1/20 | 0.71 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.71 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.71 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.71 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.71 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.71 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.71 |
| ▸ | MEN1 | O00255 | 1/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.71 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.56 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.56 |
| ▸ | OSBP | P22059 | 1/20 | 0.56 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28398375 | 1.00 | GPBAR1 (0.71) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL28194667 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL19417630 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL9179441 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL1358403 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL23008018 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL9179445 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL25522595 | 0.96 | GPBAR1 (0.72) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL9176886 | 0.96 | GPBAR1 (0.66) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 | |
| SCHEMBL7701568 | 0.92 | GPBAR1 (0.75) | GPBAR1EPHA2HSD17B10TDP1AKR1B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12529084-B2 | Method for producing phycocyanobilin using a recombinant Escherichia coli | JIANGNAN UNIVERSITY (CN) | 2026-01-20 | — | — | US | disclosed |
| CN-120019153-A | Biological production of flavonoids using microbial hosts | 德比生物技术公司 | 2025-05-16 | — | — | CN | disclosed |
| CN-119173249-A | Method for preparing chlorella extract | 奇华顿股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| CN-115135307-B | Cell delivery vehicle | 株式会社ITO | 2024-11-22 | — | — | CN | disclosed |
| CN-113207297-B | Cell population comprising embryonic erythroblasts, method for preparing same, cell culture composition and method for testing compounds | 住友化学株式会社 | 2024-09-24 | — | — | CN | disclosed |
| US-20240301454-A1 | Method for Producing Phycocyanobilin Using a Recombinant Escherichia Coli | JIANGNAN UNIVERSITY (CN) | 2024-09-12 | — | — | US | disclosed |
| CN-118591366-A | Cosmetic composition | 奇华顿股份有限公司 | 2024-09-03 | — | — | CN | disclosed |
| CN-118561970-A | Prophylactic and therapeutic immunotherapy of propionibacterium acnes | 赛诺菲巴斯德有限公司 | 2024-08-30 | — | — | CN | disclosed |
| CN-113316450-B | Use of CFTR modulators in the treatment of cerebrovascular diseases | 夸纳特制药股份公司 | 2024-05-24 | — | — | CN | disclosed |
| CN-116083333-A | Method for modifying escherichia coli to produce phycocyanin | 江南大学 | 2023-05-09 | — | — | CN | disclosed |
| CN-115397851-A | CXCL10 binding proteins and uses thereof | 哈德森医学研究院 | 2022-11-25 | — | — | CN | disclosed |
| CN-115219443-A | Conjugate | 株式会社电装 | 2022-10-21 | — | — | CN | disclosed |
| CN-114667161-A | Production system | 牛津生物医学（英国）有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-114599798-A | Method for predicting endometrial receptivity | 哈德逊医学研究所 | 2022-06-07 | — | — | CN | disclosed |
| CN-114423418-A | Compound for preventing and/or treating non-alcoholic fatty liver disease (particularly RIPA-56) | 索邦大学 | 2022-04-29 | — | — | CN | disclosed |
| CN-106029891-B | Viral vector production system | 牛津生物医学（英国）有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-113286520-A | Compositions and methods for incorporating algal heme into edible products | 特里同阿盖亚创新公司 | 2021-08-20 | — | — | CN | disclosed |
| CN-113207297-A | Cell population comprising embryo-type erythroblasts, method for producing same, cell culture composition, and method for testing compound | 住友化学株式会社 | 2021-08-03 | — | — | CN | disclosed |
| CN-105980559-B | Compositions and methods for inhibiting expression of ALAS1 gene | 阿尔尼拉姆医药品有限公司 | 2020-11-06 | — | — | CN | disclosed |
| CN-111226117-A | Liver function biomarkers | 药动生物技术公司 | 2020-06-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12529084-B2 | Method for producing phycocyanobilin using a recombinant Escherichia coli | PPOX, HMOX1, HMOX2 | GPBAR1 2130/4885EPHA2 2269/4885HSD17B10 172/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.